INFORMATION FOR
News
The findings provide evidence that the retina, the site of damage in advanced macular degeneration—the leading cause of blindness in elderly patients—is also a source for knowledge about treating neurodegenerative diseases.
We are pleased to announce that Vicente Diaz, MD, MBA, has been promoted to Chief of Ophthalmology at Bridgeport Hospital effective January 1, 2023.
Dr. Hafler has won a major $1,500,000 Cushing Foundation Award for excellence and creativity in scientific research from the H. Eric Cushing and Nancy Lurie Marks Foundations to support his research on macular degeneration.
Congratulations to Dr. Hafler on receiving an NIH R01 Research Project Grant to support his research.
This award financially supports early career physician scientists to assist them in transitioning to independent research careers.
Assistant professor of Ophthalmology and Visual Science and of pathology Brian Hafler and his team have successfully sequenced the RNA of the human retina. This work has the potential to accelerate the development of treatments for conditions such age-related macular degeneration, AMD, which is a leading cause of vision loss in the world.
Age-related macular degeneration is one of the leading causes of blindness in the elderly, affecting more than 2 million people in the United States and leading to progressive loss of central vision. Genome wide studies have identified almost three dozen genes that play a role in the disease, but exactly where in the eye they inflict damage was not well known.
Yale scientists have made an incredible genetic breakthrough by creating the first single-cell transcriptomic atlas of the human retina.